These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3034757)

  • 21. Clinical pharmacology of enalapril.
    Abrams WB; Davies RO; Gomez HJ
    J Hypertens Suppl; 1984 Dec; 2(2):S31-6. PubMed ID: 6100874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
    Tang WH; Vagelos RH; Yee YG; Fowler MB
    Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man.
    Sowers JR; Glub MS; Eggena PH; Catania RA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between acute effect of angiotensin converting enzyme inhibition and salt balance on the renal function and urinary prostanoids. Studies in healthy women.
    Agnoli GC; Borgatti R; Cacciari M; Garutti C; Ikonomu E; Lenzi P; Marinelli M; Stipo L
    Boll Soc Ital Biol Sper; 1996; 72(3-4):117-24. PubMed ID: 8771912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renin-angiotensin modulation of sympathetic reflex function in essential hypertension and in the elderly.
    Ajayi AA; Reid JL
    Int J Clin Pharmacol Res; 1988; 8(5):327-33. PubMed ID: 2852643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered dopaminergic modulation of prolactin and aldosterone secretion in pseudohypoparathyroidism.
    Sowers JR; Brickman AS; Asp N; Tuck ML; Jasberg K; Magnone S
    J Clin Endocrinol Metab; 1981 May; 52(5):914-8. PubMed ID: 7014587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects.
    Anderson PW; Malarkey WB; Salk J; Kletsky OA; Hsueh WA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):518-22. PubMed ID: 2503532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the circulating renin-angiotensin system on prolactin release in humans.
    Denolle T; Rohmer V; Saint-Adnré JP; Guyene TT; Galland F; Bigorgne JC; Schambelan M; Corvol P
    J Clin Endocrinol Metab; 1990 Jan; 70(1):288-92. PubMed ID: 2104627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of angiotensin II in the hormonal, renal, and electrolyte response to sodium restriction.
    Rogacz S; Hollenberg NK; Williams GH
    Hypertension; 1987 Mar; 9(3):289-94. PubMed ID: 3028957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potassium homeostasis during angiotensin-converting enzyme inhibition with enalapril.
    Scandling JD; Izzo JL; Pabico RC; McKenna BA; Radke KJ; Ornt DB
    J Clin Pharmacol; 1989 Oct; 29(10):916-21. PubMed ID: 2556456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum aldosterone response to metoclopramide in normal subjects and acromegalic patients.
    Zacharieva S; Stoeva I; Matrozov P; Andonova K
    Exp Clin Endocrinol; 1990 Aug; 95(3):331-8. PubMed ID: 2245821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the pathophysiologic profile of blood pressure determinants during short-term enalapril administration.
    de Leeuw PW; Birkenhäger WH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S26-9. PubMed ID: 2422490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of captopril on the plasma aldosterone response to metoclopramide in normal subjects].
    Zachariéva S; Koev D; Tcharaktchiev D; Moskov M; Andonova K
    Ann Endocrinol (Paris); 1989; 50(3):233-6. PubMed ID: 2683976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.
    Ajayi AA; Hockings N; Reid JL
    Br J Clin Pharmacol; 1986 Apr; 21(4):349-57. PubMed ID: 3011047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pressor and hormonal responses to intravenous injection of metoclopramide in normotensive and hypertensive patients.
    Kawabe H; Suzuki H; Itaya Y; Saruta T
    Jpn J Med; 1990; 29(2):174-9. PubMed ID: 2232366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of isosorbide mononitrate on hypotensive action of enalapril in patients with mild and moderate hypertension].
    Przewłocka-Kosmala M
    Pol Merkur Lekarski; 2002 Jul; 13(73):40-2. PubMed ID: 12362504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of chronic inhibition of angiotensin converting enzyme on baroreceptor reflex in essential hypertension.
    Muratani H; Kimura Y; Matsumura K; Noda Y; Eto T; Fukiyama K
    Clin Exp Hypertens A; 1988; 10 Suppl 1():391-8. PubMed ID: 2854015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tonic dopaminergic suppression of plasma aldosterone.
    Noth RH; McCallum RW; Contino C; Havelick J
    J Clin Endocrinol Metab; 1980 Jul; 51(1):64-9. PubMed ID: 7380993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.